Search
for
Sort by
Research 30 of 1000+
- Persistent Alopecia in a Breast Cancer Patient Following Taxane Chemotherapy and Adjuvant Endocrine Therapy: Case Report and Review of Post-treatment Hair Loss in Oncology Patients with Breast Cancer
- Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment
- The efficacy of an adjuvant norethisterone (jenapharm) therapy in endometrial cancer
- Nutraceuticals Known to Promote Hair Growth Do not Interfere with the Inhibitory Action of Tamoxifen in MCF7, T47D and BT483 Breast Cancer Cell Lines
- Nutraceuticals Known To Promote Hair Growth Do Not Interfere With The Inhibitory Action of Tamoxifen In MCF7, T47D And BT483 Breast Cancer Cell Lines
- Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
- Approaches to management of endocrine therapy–induced alopecia in breast cancer patients
- Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer
- Hair regrowth in endocrine therapy alopecia with dutasteride treatment in woman with estrogen positive breast cancer
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- The Use of Oral Dutasteride, Minoxidil, and Finasteride for Treating Endocrine Therapy-Induced Hair Loss from Breast Cancer Treatment: A Case Series Study
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- Study of the efficacy of carboxytherapy in alopecia
- The evolution of primary multimodality treatment in resectable breast cancer
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Exploring obesity-related endocrine disorders beyond diabetes: a narrative review
- Oral minoxidil for late alopecia in cancer survivors
- Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia
- Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients
- A case of aromatase inhibitor‐induced alopecia successfully treated with low‐dose oral minoxidil
- Systemic Circulating Leptin – Aiding New Dimension of Immune-Related Skin Carcinogenesis and Lipid Metabolism
- Cancer-Related Alopecia: From Etiologies to Global Management
- Drugs and Androgenetic Alopecia: What to look out for
- Permanent Alopecia in Breast Cancer Patients: Role of Taxanes and Endocrine Therapies
- Formestane Preferred as Second-Line Therapy in Advanced Breast Cancer
- Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients
- Alopecia With Endocrine Therapies in Patients With Cancer
- Successful Management of Post-Excisional Biopsy Dehisced Wound with 1% Framycetin Sulphate and Ozonated Oil Adjuvant: A Case Report